While everyone's competing in oversaturated markets, there's a 1.6 million km² opportunity hiding

While everyone's competing in oversaturated markets, there's a 1.6 million km² opportunity hiding in plain sight.

Mongolia has 3 million people but only 42 clinical trials (vs 25,000+ in the UK). That's not a market gap—that's a market opportunity.

Here's what forward-thinking sponsors need to know about Mongolia's emerging clinical research landscape:

✔️595x fewer trials per capita than established markets
✔️ $254M in healthcare infrastructure investment (ADB) 
✔️Government Vision 2050 prioritizing medical research 
✔️Treatment-naive populations in key therapeutic areas 
✔️Significantly lower operational costs

The regulatory framework is evolving with WHO support, and early movers could establish significant advantages before competition arrives..

Full analysis in our latest article

Back to the list